Novamind Inc.: Former LifeLabs COO Joins Novamind Leadership Team
Pierre Bou-Mansour is former COO of LifeLabs, one of Canada s largest medical service companies
TORONTO, ON / ACCESSWIRE / January 19, 2021 / Novamind Inc., (CSE:NM) ( Novamind or the Company ) a mental health company specialized in psychedelic medicine, announces the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer. Effective immediately, Mr. Bou-Mansour will assume responsibility for ensuring operational excellence as Novamind develops its network of clinics, retreats, and research sites in 2021 and beyond.
An accomplished senior executive and leader, Pierre brings a wealth of experience managing large and complex healthcare organizations. Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada s largest province with over 14 million residents. In this role, Bou-Mansour successfully le
Enhanced clinic enables greater access to ketamine and SpravatoTM treatments TORONTO, ON / ACCESSWIRE / January 13, 2021 / Novamind Inc. (CSE:NM) ("Novamind" or the "Company"), a mental health company
Press release content from Accesswire. The AP news staff was not involved in its creation.
Novamind Appoints Chuck Rifici to its Board of Directors
January 8, 2021 GMT
Closed Oversubscribed CAN$10 Million Private PlacementNot for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities lawsTORONTO, .
Closed Oversubscribed CAN$10 Million Private PlacementNot for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities lawsTORONTO, .
Entrepreneur and Executive Leader Brings Business Transformation, M&A and Regulatory Experience to Novamind
Novamind Inc.: Novamind Appoints Chuck Rifici to its Board of Directors
Entrepreneur and Executive Leader Brings Business Transformation, M&A and Regulatory Experience to Novamind
TORONTO, ON / ACCESSWIRE / January 8, 2021 / Novamind Inc. (CSE:NM) ( Novamind or the Company ), a mental health company specialized in psychedelic medicine, is pleased to update shareholders on the recent appointment of Chuck Rifici, a pioneer of the global cannabis industry, to the Company s Board of Directors. Mr. Rifici joined Novamind s Board in connection with the completion of the Company s going public transaction on the Canadian Securities Exchange. I am excited to join Novamind s Board of Directors and to support their operating model for clinical care and clinical research in psychedelic medicine, said Rifici. Scaling a world-class company in a newly regulated industry requires visionary leadership, expertise and resources, which Novamind has brought together very effectively.